G&E Herbal Biotech

G&E Herbal Biotech is a Taiwan-based biotechnology company specializing in the development of botanical drugs for unmet medical needs, particularly in oncology and inflammatory diseases. The company leverages its proprietary extraction and purification technologies to develop standardized herbal medicines that meet international regulatory standards. Its lead programs include G-Rex for cancer-related fatigue and cachexia, and GE0301 for the treatment of hepatocellular carcinoma. G&E Herbal Biotech aims to bridge traditional herbal knowledge with modern evidence-based medicine through rigorous clinical trials. The company operates out of the Southern Taiwan Science Park and is listed on the Taiwan Emerging Stock Market.